1 of 3
FEATURED COMPANIES
- Cordis Corporation
- DePuy Synthes
- Medtronic, Inc.
- Nordian
- Pfizer, Inc.
- Sirtex medical
- MORE
The global transcatheter embolization and occlusion devices market size is expected to reach USD 6.86 billion by 2026. The global market is anticipated to register a strong CAGR of 9.7% from 2019 to 2026. Key drivers of the TEO devices market include increasing adoption of minimally invasive surgeries and rising prevalence of cancer.
In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.
Asia Pacific TEO devices market is anticipated to witness highest CAGR from 2019 to 2026 due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices. Brazil was the highest revenue-generating country in Latin America in 2018. Improving healthcare services, growing medical tourism industry, and availability of regulatory framework in the country are further driving the market in Brazil
Further key findings from the study suggest:
Please note: This product will be delivered within 48 business hours after receipt of order.
In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.
Asia Pacific TEO devices market is anticipated to witness highest CAGR from 2019 to 2026 due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices. Brazil was the highest revenue-generating country in Latin America in 2018. Improving healthcare services, growing medical tourism industry, and availability of regulatory framework in the country are further driving the market in Brazil
Further key findings from the study suggest:
- Coils accounted for the largest share in 2018. Availability of a broad range of coils in various shapes and sizes enables suitable product selection for different cases, making coiling a preferred treatment for embolization
- Moreover, affordability of the commercially available devices spurs demand for coiling in occlusion
- Accessories is expected to be the largest type segment due to wide usage of accessories across various modes of embolization and occlusion
- North America along with Europe accounted for the largest share in 2018. Presence of advanced healthcare infrastructure, reimbursement coverage, and skilled professionals to perform procedures are some of the factors driving the growth of these regions
- Moreover, quick adoption of advanced healthcare treatments and products coupled with the presence of well-defined regulatory framework are boosting North America and Europe markets
- Key companies in this market include Terumo Corporation; Medtronic, Inc.; Boston Scientific Corporation; Stryker Corporation; Cordis Corporation; DePuy Synthes; St. Jude Medical; Cook Medical; Sirtex Medical Ltd.; and Noridian
Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3
FEATURED COMPANIES
- Cordis Corporation
- DePuy Synthes
- Medtronic, Inc.
- Nordian
- Pfizer, Inc.
- Sirtex medical
- MORE
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Types
1.1.2 Applications
1.1.3 Regional Scope
1.1.4 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for Primary Interviews in Europe
1.3.5.3 Data for Primary Interviews in Europe
1.3.5.4 Data for Primary Interviews in Latin America
1.3.5.5 Data for Primary Interviews in MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Objectives
1.9.1 Objective 1:
1.9.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Type Outlook
2.2.2 Application Outlook
2.2.3 Regional Outlook
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Industry Value Chain Analysis
3.3.1 Reimbursement framework
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Increasing adoption of minimally invasive surgeries
3.4.1.2 Rising prevalence of cancer
3.4.2 Market Restraint Analysis
3.4.2.1 High cost of the products
3.4.2.2 Requirement of skilled professionals
3.4.3 Industry Challenges
3.5 Transcatheter Embolization and Occlusion Devices Market Analysis Tools
3.5.1 Industry Analysis – Porter’s
3.5.1.1 Supplier Power
3.5.1.2 Buyer Power
3.5.1.3 Substitution Threat
3.5.1.4 Threat from new entrant
3.5.1.5 Competitive rivalry
3.5.2 PESTEL Analysis
3.5.2.1 Political Landscape
3.5.2.2 Technological Landscape
3.5.2.3 Economic Landscape
3.5.3 Major Deals & Strategic Alliances Analysis
3.5.4 Market Entry Strategies
Chapter 4 Type Business Analysis
4.1 Definitions and Scope
4.1.1 Coils
4.1.2 Non Coil
4.2 Type Market Share Analysis
4.3 Segment Dashboard
4.4 Global Transcatheter Embolization and Occlusion Devices by Type
4.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.6 Coils
4.6.1 Coils Market Estimates And Forecast, 2015 - 2026
4.6.2 Pushable Coils
4.6.2.1 Pushable Coils Market Estimates And Forecast, 2015 - 2026
4.6.3 Detachable Coils
4.6.3.1 Detachable Coils Market Estimates And Forecast, 2015 - 2026
4.7 Non Coils
4.7.1 Non Coils Market Estimates And Forecast, 2015 - 2026
4.7.2 Flow diverting devices
4.7.2.1 Flow Diverting Devices Market Estimates And Forecast, 2015 - 2026
4.7.3 Embolization particles
4.7.3.1 Embolization Particles Market Estimates And Forecast, 2015 - 2026
4.7.4 Liquid Embolics
4.7.4.1 Liquid Embolics Market Estimates And Forecast, 2015 - 2026
4.7.5 Others
4.7.5.1 Others Market Estimates And Forecast, 2015 - 2026
Chapter 5 Application Business Analysis
5.1 Definitions and Scope
5.1.1 Peripheral Vascular Disease
5.1.2 Oncology
5.1.3 Neurology
5.1.4 Urology
5.1.5 Others
5.2 Application Market Share Analysis
5.3 Segment Dashboard
5.4 Global Transcatheter Embolization and Occlusion Devices by Application
5.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026 for the following
5.5.1 Peripheral Vascular Disease
5.5.1.1 Peripheral Vascular Disease Market Estimates And Forecast, 2015 - 2026
5.5.1.2 Arterial Blockage
5.5.1.2.1 Arterial Blockage Market Estimates And Forecast, 2015 - 2026
5.5.1.3 Venous Blood Clot
5.5.1.3.1 Venous Blood clotMarket Estimates And Forecast, 2015 - 2026
5.5.1.4 Others
5.5.1.4.1 Others Market Estimates And Forecast, 2015 - 2026
5.5.2 Oncology
5.5.2.1 Oncology Market Estimates And Forecast, 2015 - 2026
5.5.2.2 Liver cancer
5.5.2.2.1 Liver cancer Market Estimates And Forecast, 2015 - 2026
5.5.2.3 Pancreatic cancer
5.5.2.3.1 Pancreatic cancer Market Estimates And Forecast, 2015 - 2026
5.5.2.4 Breast cancer
5.5.2.4.1 Breast cancer Market Estimates And Forecast, 2015 - 2026
5.5.2.5 Kidney cancer
5.5.2.5.1 Kidney cancer Market Estimates And Forecast, 2015 - 2026
5.5.2.6 Others
5.5.2.6.1 Others Market Estimates And Forecast, 2015 - 2026
5.5.3 Neurology
5.5.3.1 Neurology Market Estimates And Forecast, 2015 - 2026
5.5.3.2 Brain Aneurysm
5.5.3.2.1 Brain Aneurysm Market Estimates And Forecast, 2015 - 2026
5.5.3.3 Cerebral arteriovenous malformations
5.5.3.3.1 Cerebral arteriovenous malformations Market Estimates And Forecast, 2015 - 2026
5.5.3.4 Others
5.5.3.4.1 Others Market Estimates And Forecast, 2015 - 2026
5.5.4 Urology
5.5.4.1 Urology Market Estimates And Forecast, 2015 - 2026
5.5.4.2 Benign prostatic hyperplasia/Urinary retention
5.5.4.2.1 Benign prostatic hyperplasia/Urinary retention Market Estimates And Forecast, 2015 - 2026
5.5.4.3 Others (varicocele)
5.5.4.3.1 Others (varicocele) Market Estimates And Forecast, 2015 - 2026
Chapter 6 Transcatheter Embolization and Occlusion Devices Market: Regional Market Analysis, 2015 - 2026 (Value & Volume) (USD Million)
6.1 Regional market share analysis, 2018 & 2026
6.2 Regional Market Dashboard
6.3 Global Regional Market Snapshot
6.4 Regional Market Share and Leading Players, 2018
6.4.1 North America
6.4.2 Europe
6.4.3 Asia Pacific
6.4.4 Latin America
6.4.5 Middle East & Africa
6.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1 North America: SWOT Analysis
6.5.2 Europe: SWOT Analysis
6.5.3 Asia Pacific: SWOT Analysis
6.5.4 Latin America: SWOT Analysis
6.5.5 Middle East & Africa: SWOT Analysis
6.6 Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2026:
6.7 North America
6.7.1 Market estimates and forecast, 2015 - 2026 (Value & Volume)
6.7.2 U.S.
6.7.2.1 U.S. market estimates and forecast, 2015 - 2026
6.7.3 Canada
6.7.3.1 Canada market estimates and forecast, 2015 - 2026
6.8 Europe
6.8.1 Europe market estimates and forecast, 2015 - 2026
6.8.2 Germany
6.8.2.1 Germany market estimates and forecast, 2015 - 2026
6.8.3 U.K.
6.8.3.1 U.K. market estimates and forecast, 2015 - 2026
6.8.4 France
6.8.4.1 France market estimates and forecast, 2015 - 2026
6.8.5 Italy
6.8.5.1 Italy market estimates and forecast, 2015 - 2026
6.8.6 Spain
6.8.6.1 Spain market estimates and forecast, 2015 - 2026
6.9 Asia Pacific
6.9.1 Asia Pacific market estimates and forecast, 2015 - 2026
6.9.2 China
6.9.2.1 Market estimates and forecast, 2015 - 2026 (Value & Volume)
6.9.3 Japan
6.9.3.1 Japan market estimates and forecast, 2015 - 2026
6.9.4 India
6.9.4.1 India market estimates and forecast, 2015 - 2026
6.9.5 Thailand
6.9.5.1 Market estimates and forecast, 2015 - 2026 (Value & Volume)
6.9.6 South Korea
6.9.6.1 South Korea market estimates and forecast, 2015 - 2026
6.10 Latin America
6.10.1 Latin America market estimates and forecast, 2015 - 2026
6.10.2 Brazil
6.10.2.1 Brazil market estimates and forecast, 2015 - 2026
6.10.3 Mexico
6.10.3.1 Market estimates and forecast, 2015 - 2026 (Value & Volume)
6.10.4 Argentina
6.10.4.1 Argentina market estimates and forecast, 2015 - 2026
6.10.5 Columbia
6.10.5.1 Columbia market estimates and forecast, 2015 - 2026
6.11 Middle East and Africa
6.11.1 MEA Market estimates and forecast, 2015 - 2026 (Value & Volume)
6.11.2 South Africa
6.11.2.1 South Africa market estimates and forecast, 2015 - 2026
6.11.3 Saudi Arabia
6.11.3.1 Saudi Arabia market estimates and forecast, 2015 - 2026
6.11.4 UAE
6.11.4.1 UAE market estimates and forecast, 2014 - 2025
Chapter 7 Transcatheter Embolization and Occlusion Devices Market: Competitive Market Analysis,
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company/Competition Categorization
7.2.1 Innovators
7.3 Vendor Landscape
7.3.1 List of Key Distributors and Channel Partners
7.3.2 Key customers
7.3.3 Key company market share analysis, 2018
7.3.4 Boston Scientific Corporation
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Terumo Corporation
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Medtronic, Inc.
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 DePuy Synthes
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Stryker Corporation
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Cordis Corporation
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 St. Jude Medical
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.10.4 Strategic initiatives
7.3.11 Pfizer, Inc.
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.12 Sirtex medical
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 Nordian
7.3.13.1 Company overview
7.3.13.2 Financial performance
7.3.13.3 Product benchmarking
7.3.13.4 Strategic initiatives
1.1 Market Segmentation & Scope
1.1.1 Types
1.1.2 Applications
1.1.3 Regional Scope
1.1.4 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for Primary Interviews in Europe
1.3.5.3 Data for Primary Interviews in Europe
1.3.5.4 Data for Primary Interviews in Latin America
1.3.5.5 Data for Primary Interviews in MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Objectives
1.9.1 Objective 1:
1.9.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Type Outlook
2.2.2 Application Outlook
2.2.3 Regional Outlook
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Industry Value Chain Analysis
3.3.1 Reimbursement framework
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Increasing adoption of minimally invasive surgeries
3.4.1.2 Rising prevalence of cancer
3.4.2 Market Restraint Analysis
3.4.2.1 High cost of the products
3.4.2.2 Requirement of skilled professionals
3.4.3 Industry Challenges
3.5 Transcatheter Embolization and Occlusion Devices Market Analysis Tools
3.5.1 Industry Analysis – Porter’s
3.5.1.1 Supplier Power
3.5.1.2 Buyer Power
3.5.1.3 Substitution Threat
3.5.1.4 Threat from new entrant
3.5.1.5 Competitive rivalry
3.5.2 PESTEL Analysis
3.5.2.1 Political Landscape
3.5.2.2 Technological Landscape
3.5.2.3 Economic Landscape
3.5.3 Major Deals & Strategic Alliances Analysis
3.5.4 Market Entry Strategies
Chapter 4 Type Business Analysis
4.1 Definitions and Scope
4.1.1 Coils
4.1.2 Non Coil
4.2 Type Market Share Analysis
4.3 Segment Dashboard
4.4 Global Transcatheter Embolization and Occlusion Devices by Type
4.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.6 Coils
4.6.1 Coils Market Estimates And Forecast, 2015 - 2026
4.6.2 Pushable Coils
4.6.2.1 Pushable Coils Market Estimates And Forecast, 2015 - 2026
4.6.3 Detachable Coils
4.6.3.1 Detachable Coils Market Estimates And Forecast, 2015 - 2026
4.7 Non Coils
4.7.1 Non Coils Market Estimates And Forecast, 2015 - 2026
4.7.2 Flow diverting devices
4.7.2.1 Flow Diverting Devices Market Estimates And Forecast, 2015 - 2026
4.7.3 Embolization particles
4.7.3.1 Embolization Particles Market Estimates And Forecast, 2015 - 2026
4.7.4 Liquid Embolics
4.7.4.1 Liquid Embolics Market Estimates And Forecast, 2015 - 2026
4.7.5 Others
4.7.5.1 Others Market Estimates And Forecast, 2015 - 2026
Chapter 5 Application Business Analysis
5.1 Definitions and Scope
5.1.1 Peripheral Vascular Disease
5.1.2 Oncology
5.1.3 Neurology
5.1.4 Urology
5.1.5 Others
5.2 Application Market Share Analysis
5.3 Segment Dashboard
5.4 Global Transcatheter Embolization and Occlusion Devices by Application
5.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026 for the following
5.5.1 Peripheral Vascular Disease
5.5.1.1 Peripheral Vascular Disease Market Estimates And Forecast, 2015 - 2026
5.5.1.2 Arterial Blockage
5.5.1.2.1 Arterial Blockage Market Estimates And Forecast, 2015 - 2026
5.5.1.3 Venous Blood Clot
5.5.1.3.1 Venous Blood clotMarket Estimates And Forecast, 2015 - 2026
5.5.1.4 Others
5.5.1.4.1 Others Market Estimates And Forecast, 2015 - 2026
5.5.2 Oncology
5.5.2.1 Oncology Market Estimates And Forecast, 2015 - 2026
5.5.2.2 Liver cancer
5.5.2.2.1 Liver cancer Market Estimates And Forecast, 2015 - 2026
5.5.2.3 Pancreatic cancer
5.5.2.3.1 Pancreatic cancer Market Estimates And Forecast, 2015 - 2026
5.5.2.4 Breast cancer
5.5.2.4.1 Breast cancer Market Estimates And Forecast, 2015 - 2026
5.5.2.5 Kidney cancer
5.5.2.5.1 Kidney cancer Market Estimates And Forecast, 2015 - 2026
5.5.2.6 Others
5.5.2.6.1 Others Market Estimates And Forecast, 2015 - 2026
5.5.3 Neurology
5.5.3.1 Neurology Market Estimates And Forecast, 2015 - 2026
5.5.3.2 Brain Aneurysm
5.5.3.2.1 Brain Aneurysm Market Estimates And Forecast, 2015 - 2026
5.5.3.3 Cerebral arteriovenous malformations
5.5.3.3.1 Cerebral arteriovenous malformations Market Estimates And Forecast, 2015 - 2026
5.5.3.4 Others
5.5.3.4.1 Others Market Estimates And Forecast, 2015 - 2026
5.5.4 Urology
5.5.4.1 Urology Market Estimates And Forecast, 2015 - 2026
5.5.4.2 Benign prostatic hyperplasia/Urinary retention
5.5.4.2.1 Benign prostatic hyperplasia/Urinary retention Market Estimates And Forecast, 2015 - 2026
5.5.4.3 Others (varicocele)
5.5.4.3.1 Others (varicocele) Market Estimates And Forecast, 2015 - 2026
Chapter 6 Transcatheter Embolization and Occlusion Devices Market: Regional Market Analysis, 2015 - 2026 (Value & Volume) (USD Million)
6.1 Regional market share analysis, 2018 & 2026
6.2 Regional Market Dashboard
6.3 Global Regional Market Snapshot
6.4 Regional Market Share and Leading Players, 2018
6.4.1 North America
6.4.2 Europe
6.4.3 Asia Pacific
6.4.4 Latin America
6.4.5 Middle East & Africa
6.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1 North America: SWOT Analysis
6.5.2 Europe: SWOT Analysis
6.5.3 Asia Pacific: SWOT Analysis
6.5.4 Latin America: SWOT Analysis
6.5.5 Middle East & Africa: SWOT Analysis
6.6 Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2026:
6.7 North America
6.7.1 Market estimates and forecast, 2015 - 2026 (Value & Volume)
6.7.2 U.S.
6.7.2.1 U.S. market estimates and forecast, 2015 - 2026
6.7.3 Canada
6.7.3.1 Canada market estimates and forecast, 2015 - 2026
6.8 Europe
6.8.1 Europe market estimates and forecast, 2015 - 2026
6.8.2 Germany
6.8.2.1 Germany market estimates and forecast, 2015 - 2026
6.8.3 U.K.
6.8.3.1 U.K. market estimates and forecast, 2015 - 2026
6.8.4 France
6.8.4.1 France market estimates and forecast, 2015 - 2026
6.8.5 Italy
6.8.5.1 Italy market estimates and forecast, 2015 - 2026
6.8.6 Spain
6.8.6.1 Spain market estimates and forecast, 2015 - 2026
6.9 Asia Pacific
6.9.1 Asia Pacific market estimates and forecast, 2015 - 2026
6.9.2 China
6.9.2.1 Market estimates and forecast, 2015 - 2026 (Value & Volume)
6.9.3 Japan
6.9.3.1 Japan market estimates and forecast, 2015 - 2026
6.9.4 India
6.9.4.1 India market estimates and forecast, 2015 - 2026
6.9.5 Thailand
6.9.5.1 Market estimates and forecast, 2015 - 2026 (Value & Volume)
6.9.6 South Korea
6.9.6.1 South Korea market estimates and forecast, 2015 - 2026
6.10 Latin America
6.10.1 Latin America market estimates and forecast, 2015 - 2026
6.10.2 Brazil
6.10.2.1 Brazil market estimates and forecast, 2015 - 2026
6.10.3 Mexico
6.10.3.1 Market estimates and forecast, 2015 - 2026 (Value & Volume)
6.10.4 Argentina
6.10.4.1 Argentina market estimates and forecast, 2015 - 2026
6.10.5 Columbia
6.10.5.1 Columbia market estimates and forecast, 2015 - 2026
6.11 Middle East and Africa
6.11.1 MEA Market estimates and forecast, 2015 - 2026 (Value & Volume)
6.11.2 South Africa
6.11.2.1 South Africa market estimates and forecast, 2015 - 2026
6.11.3 Saudi Arabia
6.11.3.1 Saudi Arabia market estimates and forecast, 2015 - 2026
6.11.4 UAE
6.11.4.1 UAE market estimates and forecast, 2014 - 2025
Chapter 7 Transcatheter Embolization and Occlusion Devices Market: Competitive Market Analysis,
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company/Competition Categorization
7.2.1 Innovators
7.3 Vendor Landscape
7.3.1 List of Key Distributors and Channel Partners
7.3.2 Key customers
7.3.3 Key company market share analysis, 2018
7.3.4 Boston Scientific Corporation
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Terumo Corporation
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Medtronic, Inc.
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 DePuy Synthes
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Stryker Corporation
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Cordis Corporation
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 St. Jude Medical
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.10.4 Strategic initiatives
7.3.11 Pfizer, Inc.
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.12 Sirtex medical
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 Nordian
7.3.13.1 Company overview
7.3.13.2 Financial performance
7.3.13.3 Product benchmarking
7.3.13.4 Strategic initiatives
*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3
LOADING...
4 of 3
- Boston Scientific Corporation
- Terumo Corporation
- Medtronic, Inc.
- DePuy Synthes
- Stryker Corporation
- Cordis Corporation
- St. Jude Medical
- Pfizer, Inc.
- Sirtex medical
- Nordian
Note: Product cover images may vary from those shown
